10:02 AM EDT, 09/27/2024 (MT Newswires) -- Helen Torley, Director, President and CEO, on September 24, 2024, sold 30,000 shares in Halozyme Therapeutics ( HALO ) for $1,706,440. Following the Form 4 filing with the SEC, Torley has control over a total of 676,744 shares of the company, with 676,744 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1159036/000141588924024001/xslF345X05/form4-09262024_100951.xml

Price: 57.47, Change: +0.52, Percent Change: +0.91